文献速递消化内镜

针对食管胃十二指肠镜和结肠镜检查成本最小化的靶向干预对内镜资源利用的影响

The Impact on Endoscopic Resource Utilization After a Targeted Intervention for Cost-Minimization of EGD and Colonoscopy.
PubMed 文献 · Am J Gastroenterol · 2016-08-30

这项前瞻性观察性队列研究纳入6名内镜医师完成的969例治疗性门诊食管胃十二指肠镜和结肠镜检查,比较干预前(456例)与干预后(513例)阶段告知内镜医师耗材和病理标本成本对操作成本的影响。结果显示两阶段总耗材和病理成本、总耗材成本及总病理成本均无显著差异,结论为告知成本并未降低操作成本。

要点

  • 告知内镜医师耗材和病理标本成本后,总耗材和病理成本无显著差异(188.8±151.4美元 vs 188.9±151.8美元,P=0.99)。
  • 按具体操作或按每位内镜医师分析,两阶段总耗材和病理成本均无显著差异。
  • 作者认为需在其他医疗环境中及使用高成本耗材的操作中分析成本最小化策略。

核心结论

  • 通过告知内镜医师食管胃十二指肠镜和结肠镜检查中每项操作的成本使其更具成本意识,并未降低操作成本。
  • 作者认为需在其他医疗环境中及使用高成本耗材的操作中分析成本最小化策略。

研究设计与样本

  • 前瞻性观察性队列研究,纳入治疗性门诊食管胃十二指肠镜和结肠镜检查。
  • 共审查6名内镜医师完成的969例食管胃十二指肠镜、结肠镜和食管胃十二指肠镜+结肠镜检查,干预前阶段456例,干预后阶段513例。
  • 干预前阶段内镜医师未被告知操作中耗材或病理标本的成本;在3周干预期及干预后阶段,内镜医师在所有操作完成后被告知耗材和病理标本的美元价值,均使用机构成本而非收费,且内镜医师对观察设盲。

主要发现

  • 干预前阶段与干预后阶段总耗材和病理成本(美元)无显著差异(188.8±151.4 vs 188.9±151.8,P=0.99)。
  • 干预前阶段与干预后阶段总耗材成本无显著差异(36.2±107.9 vs 39.0±95.96,P=0.67)。
  • 干预前阶段与干预后阶段总病理成本无显著差异(152.6±101.3 vs 149.9±112.5,P=0.70)。
  • 按具体操作或按每位内镜医师分析,干预前阶段与干预后阶段总耗材和病理成本均无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The need to define the cost of endoscopic procedures becomes increasingly important in an era of providing low-cost, high-quality care. We examined the impact of informing endoscopists of the cost of accessories and pathology specimens as a cost-minimization strategy. METHODS: We conducted a prospective observational cohort study of therapeutic outpatient esophagogastroduodenoscopy (EGD) and colonoscopy. During the pre-intervention phase (phase 1), the endoscopists were not briefed on the cost of accessories or pathology specimens obtained during the procedure. During a 3-week intervention phase and the post-intervention phase (phase 2) endoscopists were informed of the dollar value of accessories and pathology specimens after the completion of all procedures. In all cases the institutional costs (not charges) were used. The endoscopists were blinded to their observation. RESULTS: A total of 969 EGD, colonoscopy, and EGD+colonoscopy performed by 6 endoscopists were reviewed, 456 procedures in phase 1 and 513 procedures in phase 2. There was no significant difference between phases 1 and 2 in total device and pathology cost in dollars (188.8±151.4 vs. 188.9±151.8, P=0.99), total device cost (36.2±107.9 vs. 39.0±95.96, P=0.67) and total pathology cost (152.6±101.3 vs. 149.9±112.5, P=0.70). There was not a significant difference in total device and pathology cost when examined by specific procedures performed, or for any of the endoscopists between phases 1 and 2. CONCLUSIONS: Making endoscopists more cost conscious by informing them of the costs of each procedure during EGD and colonoscopy does not result in lower procedural costs. Analysis of cost-minimization strategies involving procedures in other health-care settings and procedures using high-cost accessories are warranted.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Kaitha SR, Salem G, Zhao YD, et al. The Impact on Endoscopic Resource Utilization After a Targeted Intervention for Cost-Minimization of EGD and Colonoscopy. Am J Gastroenterol. 2016. PMID: 27575709. doi:10.1038/ajg.2016.340

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。